Cargando…

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

The most common subtype of ovarian cancer (OC) is the high-grade serous ovarian carcinoma (HGSOC), accounting for 70%–80% of all OC deaths. Although HGSOC is a potentially immunogenic tumor, clinical studies assessing the effectiveness of inhibitors of programmed death protein and its ligand (PD-1/P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fanale, Daniele, Corsini, Lidia Rita, Brando, Chiara, Cutaia, Sofia, Di Donna, Mariano Catello, Filorizzo, Clarissa, Lisanti, Maria Chiara, Randazzo, Ugo, Magrin, Luigi, Romano, Raffaella, Bazan Russo, Tancredi Didier, Olive, Daniel, Vieni, Salvatore, Pantuso, Gianni, Chiantera, Vito, Russo, Antonio, Bazan, Viviana, Iovanna, Juan Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532861/ https://www.ncbi.nlm.nih.gov/pubmed/36212445 http://dx.doi.org/10.3389/fonc.2022.946319

Ejemplares similares

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
por: Bian, Benjamin, et al.
Publicado: (2019)

Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
por: Fanale, Daniele, et al.
Publicado: (2021)

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer
por: Fanale, Daniele, et al.
Publicado: (2023)

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions
por: Incorvaia, Lorena, et al.
Publicado: (2020)

Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay
por: Incorvaia, Lorena, et al.
Publicado: (2023)

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
por: Blazquez, Juan-Luis, et al.
Publicado: (2018)

Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology
por: Vantourout, Pierre, et al.
Publicado: (2018)

Altered expression of Butyrophilin (BTN) and BTN‐like (BTNL) genes in intestinal inflammation and colon cancer
por: Lebrero‐Fernández, Cristina, et al.
Publicado: (2016)

Btn3 is a negative regulator of Btn2-mediated endosomal protein trafficking and prion curing in yeast
por: Kanneganti, Vydehi, et al.
Publicado: (2011)

Investigation of the intramolecular hydrogen bonding interactions and excited state proton transfer mechanism for both Br-BTN and CN-BTN systems
por: Yang, Dapeng, et al.
Publicado: (2019)

Caveat: Monoclonal antibodies 20.1 and 103.2 bind all human BTN3A proteins and are not suited to study BTN3A1-specific features
por: Herrmann, Thomas
Publicado: (2023)

Reply to Herrmann: The BTN3A isoform BTN3A1 is responsible for phosphoantigen-induced Vγ9Vδ2 T cell activation
por: Zhou, Jiaqing, et al.
Publicado: (2023)

Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors
por: Chen, Sihan, et al.
Publicado: (2021)

pH-dependent localization of Btn1p in the yeast model for Batten disease
por: Wolfe, Devin M., et al.
Publicado: (2011)

CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1
por: Ishemgulova, Aygul, et al.
Publicado: (2018)

Akt1 Is Essential for Postnatal Mammary Gland Development, Function, and the Expression of Btn1a1
por: LaRocca, Jessica, et al.
Publicado: (2011)

Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
por: Fanale, Daniele, et al.
Publicado: (2022)

Bioinformatics Training Network (BTN): a community resource for bioinformatics trainers
por: Schneider, Maria V., et al.
Publicado: (2012)

ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells
por: Riganti, Chiara, et al.
Publicado: (2018)

BTN1, the Saccharomyces cerevisiae homolog to the human Batten disease gene, is involved in phospholipid distribution
por: Padilla-López, Sergio, et al.
Publicado: (2012)

TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh
por: Zhao, Limin, et al.
Publicado: (2020)

Occludin is a target of Src kinase and promotes lipid secretion by binding to BTN1a1 and XOR
por: Lu, Yunzhe, et al.
Publicado: (2022)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
por: Kone, Abdou-samad, et al.
Publicado: (2022)

BTN2A2, a new biomarker and therapeutic target for glioma
por: Wang, Heping, et al.
Publicado: (2023)

btn1 Affects Endocytosis, Polarization of Sterol-Rich Membrane Domains and Polarized Growth in Schizosaccharomyces pombe
por: Codlin, Sandra, et al.
Publicado: (2008)

The yeast Batten disease orthologue Btn1 controls endosome–Golgi retrograde transport via SNARE assembly
por: Kama, Rachel, et al.
Publicado: (2011)

Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters
por: Rhodes, David A., et al.
Publicado: (2018)

A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming
por: Incorvaia, Lorena, et al.
Publicado: (2020)

Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin
por: Rhodes, David A., et al.
Publicado: (2015)

Comprehensive analysis of BTN3A1 in cancers: mining of omics data and validation in patient samples and cellular models
por: Liang, Fan, et al.
Publicado: (2021)

Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength
por: Fanale, Daniele, et al.
Publicado: (2022)

BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
por: Chen, Sihan, et al.
Publicado: (2022)

Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes
por: Sarter, Kerstin, et al.
Publicado: (2016)

BTN2A2 protein negatively regulates T cells to ameliorate collagen-induced arthritis in mice
por: He, Xueping, et al.
Publicado: (2021)

BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma
por: Lin, Yuansheng, et al.
Publicado: (2022)

BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy
por: Yang, Wenjing, et al.
Publicado: (2022)

BTN2A1-BRAF fusion may be a novel mechanism of resistance to osimertinib in lung adenocarcinoma: a case report
por: Kong, Wei-Min, et al.
Publicado: (2023)

Prioritized Expression of BTN2 of Saccharomyces cerevisiae under Pronounced Translation Repression Induced by Severe Ethanol Stress
por: Yamauchi, Yukina, et al.
Publicado: (2016)

Identification of the primate-specific gene BTN3A2 as an additional schizophrenia risk gene in the MHC loci
por: Wu, Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_43elnaqvegkhivn9rn7haqr2ts